Litcius/Paper detail

Therapeutic effect of uridine phosphorylase 1 (UPP1) inhibitor on liver fibrosis in vitro and in vivo

Elisa Feller Gonçalves da Silva, Bruna Pasqualotto Costa, Marcella Tornquist Nassr, Bruno de Souza Basso, Matheus Scherer Bastos, Géssica Luana Antunes, Camille Kirinus Reghelin, Maria Cláudia Rosa Garcia, Vitor Giancarlo Schneider Levorse, Leonardo Pfeiff Carlessi, Krist Helen Antunes, Carine Raquel Richter Schmitz, Gabriela Viegas Haute, Carolina Luft, Eliane Romanato Santarém, Florencia María Barbé‐Tuana, Márcio Vinı́cius Fagundes Donadio, Luiz Augusto Basso, Pablo Machado, Jarbas Rodrigues de Oliveira

2020European Journal of Pharmacology19 citationsDOIOpen Access PDF

Topics & Concepts

In vivoBleomycinPharmacologyHepatic stellate cellFibrosisUridineChemistryIn vitroCarbon tetrachlorideBiochemistryBiologyMedicineInternal medicineEndocrinologyChemotherapyRNABiotechnologyGeneOrganic chemistryLiver physiology and pathologyLiver Disease Diagnosis and TreatmentLiver Diseases and Immunity
Therapeutic effect of uridine phosphorylase 1 (UPP1) inhibitor on liver fibrosis in vitro and in vivo | Litcius